CWR22: The first human prostate cancer xenograft with strongly: Androgen-dependent and relapsed strains both in vivo and in soft agar

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3042-3046

  Nagabhushan, Moolky ^a   Miller, Casey M ^a   Pretlow, Theresa P ^a   Giaconia, Joseph M ^a   Edgehouse, Nancy L ^a   Schwartz, Stuart ^a   Kung, Hsing Jien ^a   De Vere White, Ralph W ^b   Gumerlock, Paul H ^b   Resnick, Martin I ^a   Amini, Saeid B ^a   Pretlow, Thomas G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ANIMAL TISSUE; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR XENOGRAFT;

AGAR; ANDROGENS; ANIMALS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; ORCHIECTOMY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029942883     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Resnick, M. I., and Grayhack, J. T. Treatment of stage IV carcinoma of the prostate. Urol. Clin. North Am., 2: 141-161, 1975.
2. Schrôder, F. H Endocrine therapy where do we stand and where are we going? In: L M. Franks (ed.), Prostate Cancer Cell and Molecular Mechanisms in Diagnosis and Treatment. Cancer Surveys, Vol 11, pp. 177-194. Plainview. NY: Cold Spring Harbor Laboratory Press, 1991.
3. Gleave, M. E., Hsieh, J-T., Wu, H-C., von Eschenbach, A. C., and Chung, L. W. K. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res., 52: 1598-1605, 1992.
4. Zhao, X., van Steenbrugge, G. J., and Schrôder, F. H. Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor. Urol. Res , 20: 193-197, 1992.
5. van Steenbrugge, G. J , van Weerden, W. M , de Ridder, C M A , van der Kwast, T. H., and Schrôder, F. H. Development and application of prostatic xenograft models for the study of human prostate cancer. In. M. Motta and M. Serio (eds ), Sex Hormones and Antihormones in Endocrine Dependent Pathology Basic and Clinical Aspects, pp. 11-22. Amsterdam: Elsevier, 1994.
6. Wainstein, M. A., He, F., Robinson, D., Kung, H-J., Schwartz, S., Giaconia, J. M., Edgehouse, N. L , Pretlow, T. P., Bodner, D. R., Kursh, E. D., Resnick, M. I., Seftel, A , and Pretlow, T. G. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res., 54: 6049-6052, 1994.
7. Pretlow, T G., Wolman, S. R., Micale, M. A., Pelley, R. J , Kursh, E. D., Resnick, M. I., Bodner, D. R., Jacobberger, J. W , Delmoro, C. M., Giaconia, J. M., and Pretlow, T. P. Xenografts of primary human prostatic carcinoma. J. Natl. Cancer Inst., 85: 394-398, 1993
8. Pretlow, T. G., Pretlow, T P., Yang, B., Kaetzel, C. S , Delmoro, C. M., Kamis, S. M., Bodner, D. R., Kursh, E., Resnick, M. I., and Bradley, E. L., Jr Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia. Int. J. Cancer, 49: 645-649, 1991
9. Hamburger, A. W., and Salmon, S. E. Primary bioassay of human tumor stem cells. Science (Washington DC), 197: 461-463, 1977.
10. Pretlow, T. G., Ogrinc, G. S., Amini, S. B., Delmoro, C. M., Molkentin, K. F., Wulson, J K. V., and Pretlow, T. P. A better defined medium for human prostate cancer cells. In Vitro Cell Dev. Biol., 29A: 528-530, 1993.
11. Buick, R. N., Stanisic, T. H., Fry, S. E. Salmon, S. E., Trent, J. M., and Kransovich, P. Development of an agar-methylcellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder. Cancer Res., 39: 5051-5056, 1979.
12. Rosenthal, A., Lindquist, P. B , Bringmaa, T. S., Goeddel, D. V., and Derynck, R. Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation. Cell, 46: 301-309, 1986.